Bank Of America Corp Sab Biotherapeutics, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.62 - $1.0 $33 - $54	54 New	54 $0
Q4 2022 Feb 10, 2023	SELL	$0.54 - $9.8 $233 - $4,233	-432 Reduced 91.91%	38 $0
Q3 2022 Nov 14, 2022	SELL	$0.13 - $12.4 $39 - $3,794	-306 Reduced 39.43%	470 $0
Q2 2022 Aug 12, 2022	SELL	$1.11 - $3.46 $2,223 - $6,930	-2,003 Reduced 72.08%	776 $1,000
Q1 2022 May 16, 2022	BUY	$1.78 - $8.5 $1,076 - $5,142	605 Added 27.83%	2,779 $10,000
Q4 2021 Feb 08, 2022	BUY	$7.3 - $11.24 $15,870 - $24,435	2,174 New	2,174 $16,000

529K

Ticker SABS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,030,900
Market Cap $111M
Description
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.